Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Moleculin Biotech, Inc.

NASDAQ: MBRX · Life Sciences · 16 alerts · CIK 1659617

Share price
$7.14Close, Nov 16
Market cap
$7.58M
Shares outstanding
1.06MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Moleculin Biotech, Inc. filings on SEC EDGAR ↗

8:38 AM ET 8-K
Business Update

Moleculin Biotech Business Update

Moleculin Biotech announced the grant of Australian Patent No. 2020303572, which covers the preparation of preliposomal Annamycin lyophilizate. The patent was granted jointly to Moleculin and The Board of Regents of The University of Texas System, strengthening the company's international intellectual property portfolio for its lead drug candidate, Annamycin.

Counterparty
The Board of Regents of The University of Texas System

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.